The UK National Screening Committee has recently published a blog reporting significant progress with SMA in service evaluation planning. Members of the […]
Read moreThe results of an important study by Oliver Schawrtz et al. were published today in JAMA Pediatrics along with an […]
Read moreAs more countries introduce newborn screening for Spinal Muscular Atrophy (SMA), it is important that UK babies with SMA do […]
Read moreThe Thames Valley Pilot Study for newborn screening for SMA has had to be renamed due to its expanding focus […]
Read moreYou may have seen in our social media feed that the UK NSC recently published a blog on work that […]
Read moreThe UK SMA Newborn Screening Alliance was delighted to see SMA included in the initial list of over 200 rare […]
Read moreThe National Board of Health and Welfare in Sweden has introduced national screening for spinal muscular atrophy (SMA) in newborns. […]
Read moreOn 7 August, NHS England issued a news release highlighting that 3 in 4 babies born with SMA are now […]
Read moreThe UK NSC has published a blog today that summarises progress on the assessment of newborn screening for SMA. We […]
Read moreA new academic article, co-authored by Alliance Chair Laurent Servais, has been published. Laurent and his colleagues undertook a systematic […]
Read moreThe UK SMA Newborn Screening Alliance is focused on ensuring that a positive decision is made about newborn screening for […]
Read moreThe All-Party Parliamentary Group (APPG) for Muscular Dystrophy has published a report on newborn screening for rare conditions. The report […]
Read moreAlthough the UK SMA Newborn Screening Alliance originally convened prior to the pandemic, disruption due to Covid meant that the […]
Read moreA new paper, developed in partnership with leading clinicians, summarises the clear, well-defined treatment pathways for babies diagnosed with SMA […]
Read moreAs part of its decision-making process, the UK National Screening Committee (UK NSC) considers economic modelling to be important for […]
Read moreAn evidence review process is applied to all decisions that the UK NSC (National Screening Committee) makes regarding whether to […]
Read moreOn Thursday 9th March 2023, a Westminster Hall debate was held in the House of Commons to consider “Patients with […]
Read moreThe UK SMA Newborn Screening Alliance is delighted that Zolgensma™ (Onasemnogene abeparvovec) is now recommended as an option for treating […]
Read moreResearchers at the University of Warwick, Prof Felicity Boardman and Dr Corinna Clark, are conducting a study to explore the […]
Read moreIn March 2023, SMA UK recorded a webinar to bring the wider community up to speed on developments in relation […]
Read moreA new study published in The Lancet Child & Adolescent Health journal suggests that newborn screening for spinal muscular atrophy […]
Read moreSMA UK, Muscular Dystrophy UK and TreatSMA recently issued an update related to a decision by NHS England to temporarily […]
Read moreThe Alliance is delighted that the UK National Screening Committee (UK NSC) review of spinal muscular atrophy (SMA) for the […]
Read moreA new model has been developed to explore the cost effectiveness of screening for spinal muscular atrophy (SMA) in England. […]
Read moreYesterday, NHS England published its 5-year genomics strategy, Accelerating Genomics Medicine in the NHS. In conjunction with the release of […]
Read moreThe APPG on Muscular Dystrophy has launched an inquiry to gain a better understanding of the value of newborn screening […]
Read moreSMA newborn screening has now been added to the screening programme in Galicia, Spain with screening expected to start by […]
Read moreWe’re pleased to announce the launch of our new website, and social media channels, for the UK SMA Newborn Screening […]
Read moreThe Alliance welcomes the establishment of the UK National Screening Committee’s (UK NSC) new Blood Spot Task Group (BSTG). There […]
Read moreOur Chair, Laurent Servais, has released a video (click below) that explains the impact that treatment for SMA can have […]
Read moreThe UK SMA Newborn Screening Alliance Steering Group, chaired by Professor Laurent Servias (Professor of Paediatric Neuromuscular Diseases, University of […]
Read moreThe new chair of the UK National Screening Committee (UK NSC), Professor Sir Mike Richards, announced today the expansion of […]
Read moreThe Minister for Population Health, Wellbeing and Sports announced today that SMA will be included in the newborn heel prick […]
Read moreFirst UK pilot study of newborn screening for SMA was launched in Oxford. The aim of the study is to […]
Read moreLatest data from the SPR1NT trial has been released, again confirming the impact of Zolgensma for children at risk for […]
Read moreA group of healthcare professionals involved in the diagnosis and care of people SMA in Scotland published a paper in […]
Read moreThe Guardian has published an article emphasising the importance of treating SMA pre-symptomatically, with a focus in the difference in […]
Read moreA new study, “Evolving approaches to prenatal genetic counselling for Spinal Muscular Atrophy in the new treatment era”, has been […]
Read moreProfessor Laurent Servais, gave a talk at an online event entitled ‘Newborn Screening: What Should Be Screened for and How?’, […]
Read moreHe showed three studies, with three different medications, which all show that a patient treated after the onset of symptoms […]
Read more